This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Objective: To compare the 24-hour sustained efficacy and safety of a new tramadol once-daily formulation (tramadol OAD) using Contramid ® controlled-release technology with a marketed twice-daily ...
This study showed that a multiple-units SR formulation (capsule) produced smoother tramadol plasma concentration profiles than a single-unit SR formulation (tablet), whilst maintaining equivalent ...
It engaged key policy makers and practitioners from national, international and non-government agencies with research on the trade in Tramadol and the transport of migrants in Nigeria and Niger. The ...